Endometrial gene therapy
OA: closed
AI-generated summary
This patent describes a uterine gene therapy method using liposome-mediated transfection to manipulate Hox genes, which are relevant to endometriosis and embryonic implantation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A method for treating the uterus includes transfecting the uterus with a liposome-mediated gene. Hox genes have been found particularly relevant to diseases such as endometriosis, and manipulation of their expression can affect embryonic implantation.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-29T06:27:48.050232+00:00